This site uses cookies to collect
anonymous information about how visitors use the site and to remember user choices. By continuing to browse this website you are agreeing that these types of cookies can be placed on your device. View our Cookie Policy here.
X
Veeda
Country: US, India, Malaysia
Market: Global
Date of original investment: 2006
Deal type: Expansion
Research services for the world
In the 1970s, the phrase ‘brain-drain’ would often come up in conversations about India’s educated and skilled workforce - referring to the migration of Indian knowledge workers abroad, as they searched for opportunities then unavailable in India.

It’s a different story today. From manufacturing to services, knowledge to research, India has become a skills hub, attracting businesses and people alike. Veeda Clinical Research (‘Veeda’) is one of the companies benefitting from this transformation. Veeda is the largest clinical Contract Research Organisation (‘CRO’) in India with a diverse product offering and a geographical footprint that spans India, Europe, and the United States.

Veeda operates in two distinct areas, Early Clinical Development (‘ECD’) and Oncology. It is one of the few CROs outside of the US and the EU that has performed ‘first-into-man’ studies for presentation to US FDA for approvals. With its well developed product portfolio, Veeda Oncology offers drug companies a complete service to support the complex development of cancer-targeting medicines.